Related Experiment Video
Updated: Aug 7, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Aminoglycosides, imipenem, and aztreonam
1College of Pharmacy, University of Texas, Austin.
Aminoglycosides remain crucial for serious gram-negative infections. Newer antibiotics like imipenem and aztreonam offer broad-spectrum or specific gram-negative coverage, but do not fully replace aminoglycoside therapy.
Area of Science:
- Pharmacology
- Microbiology
- Infectious Diseases
Background:
- Aminoglycosides are essential for treating serious gram-negative aerobic bacterial infections.
- Newer antibiotics, including beta-lactams and fluoroquinolones, have emerged but aminoglycosides remain a cornerstone therapy.
- Imipenem and aztreonam represent significant advancements in antibacterial agents.
Purpose of the Study:
- To review the pharmacology and clinical utility of aminoglycosides.
- To discuss the properties and applications of imipenem and aztreonam.
- To compare the efficacy and scope of these antibiotic classes.
Main Methods:
- Review of existing literature on aminoglycosides, imipenem, and aztreonam.
- Analysis of pharmacological profiles, including spectrum of activity and toxicity.
- Evaluation of clinical utility in treating serious bacterial infections.
Main Results:
- Aminoglycosides are vital for gram-negative aerobic pathogens.
- Imipenem exhibits the broadest spectrum of activity among the agents discussed.
- Aztreonam is effective against aerobic gram-negative bacteria but is not a direct substitute for aminoglycosides.
Conclusions:
- Aminoglycosides, imipenem, and aztreonam are important therapeutic options for serious bacterial infections.
- Each agent possesses unique pharmacological properties and clinical applications.
- Understanding their respective roles is crucial for effective antibiotic selection.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Acute Pyelonephritis II: Diagnostic Studies and Management
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Anthelminthic Agents

